|
|
|
|
ZENN Motor Company Completes Additional Equity Investment in EEStor, Inc
ZENN Motor Company Inc.('ZMC' or 'the Company') (TSX VENTURE: ZNN) announced today that it has increased its equity investment in energy storage developer, EEStor, Inc. with an additional US $5.0 million investment. The ...
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
This report firstly gives an overview of China bio-pharmaceutical industry, and then analyses sub-industries, import & exports status of the industry; finally it expounds the operations and revenue, project investment, main...
|
|
|
Warm biotech welcome for 150 million Innovation Fund
The UK Governments plans to create a new 150 million fund to promote innovation has received enthusiastic support from leading lights in the countrys life science industry.The UK Innovation Investment Fund will be used to help...
|
|
|
Zacks Releases Four Powerful ''Buy'' Stocks: Flanders Corp., Altera Corp., Dr. Reddy's Lab Ltd. and Kinetic Co
CHICAGO-- (BUSINESS WIRE) -- Four free stock picks are being made available today on Zacks.com.The industrys leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main...
|
|
|
Investment Planning Counsel Inc. Reports June 2009 Mutual Fund Sales and Assets Under Management
Counsel Group of Funds Inc., a division of Investment Planning Counsel, Inc., today reported preliminary mutual fund sales and assets under management for the month ending June 30, 2009.Mutual fund assets under management were $1.84...
|
|
|
Pharmaceutical Product Development (PPDI) Mature Trend: 5.4% Move in 122 Days
Disclaimer: The Connors Group, Inc.('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should...
|
|
|
Genzyme (GENZ) Momentum Alert: 3.6% Move in 17 Days
Disclaimer: The Connors Group, Inc.('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should...
|
|
|
Financings roundup: SBi raises $108M 'D' round; Lumenis gets $15 million
A Medical Device Daily Staff Report At a time when medical device companies are struggling to keep afloat it is refreshing to see there are still some companies out there that have managed to bring in some significant cash.Small Bone...
|
|
|
Myriad Genetics Dropped Wednesday On Q4 Forecast
Disclaimer: The Connors Group, Inc.('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should...
|
|
|
Teva Rose Wednesday On FDA Decision, Extends High
Disclaimer: The Connors Group, Inc.('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should...
|
|
|
SmarTrend(R) News Watch: Sepracor Shares Slump on Depression Drug Disappointment
Disclaimer: The Connors Group, Inc.('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should...
|
|
|
Elekta and Swedfund Invest in Cancer Care in Developing Countries
The medical technology company Elekta (STO:EKTAB) has formed an investment company, Global Medical Investments 'GMI', with Swedfund International AB for financing and establishment of cancer care projects in developing countries....
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue.http://www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio-pharmaceutical-Companies-Report-2008.html This...
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
Reportlinker.com announces that a new market research report is available in its catalogue.Reportlinker Adds China Listed Bio-pharmaceutical Companies Report, 2008 : www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio .. :...
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue.http://www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio-pharmaceutical-Companies-Report-2008.html This...
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
NEW YORK--(BUSINESS WIRE)-- Reportlinker.com announces that a new market research report is available in its catalogue.This report firstly gives an overview of China bio-pharmaceutical industry, and then analyses sub-industries, import ...
|
|
|
Reportlinker Adds China Listed Bio-Pharmaceutical Companies Report, 2008
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue.http://www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio-pharmaceutical-Companies-Report-2008.html This...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Invest First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline Equity Investment Provides...
|
|
|
ELAN CORPORATION PLC - Johnson & Johnson, Elan Announce Definitive Agreement
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment WEBWIRE Thursday, July 02, 2009 First-in-Class Alzheimer's Treatments Expand Existing J&J...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
% Enter Symbols: Sponsored by: and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline...
|
|
|
BiomedReports: Russell Investments' exclusive list adds Insmed (NASDAQ:INSM), Lannett Company (AMEX:LCI), Medi
BioMedReports.Com, the news portal covering the biomedical sector that delivers financial and investment intelligence to a community of highly informed investors has unveiled the big lineup of healthcare sector companies who were...
|
|
|
ELAN CORPORATION PLC - Johnson & Johnson, Elan Announce Definitive Agreement
(PR Newswire Europe via COMTEX) -- JNJ | Quote | Chart | News | PowerRating -- e>Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First...
|
|
|
REG-Elan Corporation PLC: Johnson & Johnson, Elan Announce Definitive Agreement
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline Johnson &...
|
|
|
Gyros AB raises 7.5M for biopharma development technology
which specialises in automated micro-immunoassays for developing protein drugs, has raised SEK 80 million (7.5 million) in a fundraising led by SLS Invest, the leading shareholder.The new funds will enableto drive the further...
|
